Sundrug Statistics

Total Valuation

Sundrug has a market cap or net worth of JPY 466.41 billion. The enterprise value is 445.35 billion.

Market Cap	466.41B
Enterprise Value	445.35B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Mar 30, 2026

Share Statistics

Sundrug has 116.98 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	116.98M
Shares Outstanding	116.98M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	4.61%
Owned by Institutions (%)	28.02%
Float	67.82M

Valuation Ratios

The trailing PE ratio is 14.97 and the forward PE ratio is 13.70. Sundrug's PEG ratio is 2.69.

PE Ratio	14.97
Forward PE	13.70
PS Ratio	0.56
PB Ratio	1.67
P/TBV Ratio	1.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.69

Financial Ratio History

Enterprise Valuation

EV / Earnings	14.30
EV / Sales	0.53
EV / EBITDA	6.97
EV / EBIT	9.89
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.18.

Current Ratio	1.72
Quick Ratio	0.75
Debt / Equity	0.18
Debt / EBITDA	0.75
Debt / FCF	n/a
Interest Coverage	144.43

Financial Efficiency

Return on equity (ROE) is 11.50% and return on invested capital (ROIC) is 12.34%.

Return on Equity (ROE)	11.50%
Return on Assets (ROA)	6.39%
Return on Invested Capital (ROIC)	12.34%
Return on Capital Employed (ROCE)	13.91%
Weighted Average Cost of Capital (WACC)	4.17%
Revenue Per Employee	116.71M
Profits Per Employee	4.36M
Employee Count	7,145
Asset Turnover	1.84
Inventory Turnover	5.88

Taxes

In the past 12 months, Sundrug has paid 14.38 billion in taxes.

Income Tax	14.38B
Effective Tax Rate	31.58%

Stock Price Statistics

The stock price has decreased by -5.32% in the last 52 weeks. The beta is 0.06, so Sundrug's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	-5.32%
50-Day Moving Average	4,203.00
200-Day Moving Average	4,381.14
Relative Strength Index (RSI)	33.98
Average Volume (20 Days)	427,315

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sundrug had revenue of JPY 833.92 billion and earned 31.15 billion in profits. Earnings per share was 266.31.

Revenue	833.92B
Gross Profit	213.55B
Operating Income	46.22B
Pretax Income	45.53B
Net Income	31.15B
EBITDA	65.12B
EBIT	46.22B
Earnings Per Share (EPS)	266.31

Full Income Statement

Balance Sheet

The company has 70.02 billion in cash and 48.97 billion in debt, giving a net cash position of 21.06 billion or 180.02 per share.

Cash & Cash Equivalents	70.02B
Total Debt	48.97B
Net Cash	21.06B
Net Cash Per Share	180.02
Equity (Book Value)	278.81B
Book Value Per Share	2,383.37
Working Capital	99.81B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 25.61%, with operating and profit margins of 5.54% and 3.74%.

Gross Margin	25.61%
Operating Margin	5.54%
Pretax Margin	5.46%
Profit Margin	3.74%
EBITDA Margin	7.81%
EBIT Margin	5.54%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 132.00, which amounts to a dividend yield of 3.29%.

Dividend Per Share	132.00
Dividend Yield	3.29%
Dividend Growth (YoY)	0.77%
Years of Dividend Growth	7
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	3.25%
Earnings Yield	6.68%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.

Last Split Date	Mar 29, 2017
Split Type	Forward
Split Ratio	2

Scores

Sundrug has an Altman Z-Score of 4.77 and a Piotroski F-Score of 4.

Altman Z-Score	4.77
Piotroski F-Score	4